← Leaderboards
Fatih M Uckun
Children'S Hospital Of Los Angeles
$4,259,827
Attributed
$4,259,827
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999.7K · FY2010–15$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,259,827 · 3
By mechanism
U01$2,252,692 · 1
R01$1,630,120 · 1
R21$377,015 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Xenograft Model”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- David Heimbrook · Leidos Biomedical Research, Inc.$97,842,001
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Samuel Singer · Sloan-Kettering Inst Can Research$23,058,247
- Larry Arthur$20,604,376
Research focus
Xenograft ModelIn VivoLeukemia, Lymphocytic, AcuteToxic EffectDisease-Free SurvivalApoptoticIn VitroLeukemiaMalignant NeoplasmsResearch Project GrantsDoseCd19 GeneResistanceScid MiceApoptosisCellsChemotherapyFoundationsBinding (Molecular Function)Inhibitor/AntagonistSiteSyk GeneAffectDrug Candidate
Grant awards (12)
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL$332,000
R01 · FY2015 · CA · contact PI
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles$417,323
U01 · FY2014 · CA · contact PI
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL$322,040
R01 · FY2014 · CA · contact PI
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles$416,542
U01 · FY2013 · CA · contact PI
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL$312,080
R01 · FY2013 · CA · contact PI
Amplifying Radiation Potency Against Leukemic Stem Cells$165,605
R21 · FY2013 · CA · contact PI
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles$456,297
U01 · FY2012 · CA · contact PI
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL$332,000
R01 · FY2012 · CA · contact PI
Amplifying Radiation Potency Against Leukemic Stem Cells$211,410
R21 · FY2012 · CA · contact PI
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles$470,120
U01 · FY2011 · CA · contact PI
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL$332,000
R01 · FY2011 · CA · contact PI
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles$492,410
U01 · FY2010 · CA · contact PI